IP injects £½m for revolutionary monitoring device
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.New technology that could revolutionise the way doctors measure patients' vital signs has attracted a £500,000 investment from the intellectual property firm IP Group.
The device, which uses a webcam and computer software, allows medical staff to measure heart rate, respiratory rate and, uniquely, oxygen saturation.
The package could cut back on the need for patients to make repeated visits to doctors. It also has possible applications in gyms and rest homes.
The device has been developed by Oxehealth, a commercial spin-out from Oxford University's Institute of Biomedical Engineering.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments